CIK 0001812364
- Large accelerated filer
Relay Therapeutics, Inc.
Sign in to watch- Ticker
- RLAY
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 617-370-8837
- Business address
- 60 HAMPSHIRE STREET, CAMBRIDGE, MA, 02139
- 4 Open-market sale Chief Administrative Officer sold 259 shares at $22.73 ($5,887)
- 4 Open-market sale Chief Financial Officer sold 443 shares at $22.73 ($10,069)
- 4 Open-market sale President, R&D sold 976 shares at $22.73 ($22,184)
- 4 Open-market sale Chief Legal Officer sold 294 shares at $22.73 ($6,683)
- 4 Open-market sale President and CEO sold 42,000 shares at an average $24.24 ($1,018,080)
- 4 Open-market sale Director sold 25,000 shares at $29.95 ($748,750)
- 4 Open-market sale Chief Financial Officer sold 26,257 shares at $30.00 ($787,710)
- 4 Open-market sale President, R&D sold 25,000 shares at $30.00 ($750,000)
- 4 Open-market sale President, R&D sold 4,900 shares at $25.46 ($124,754)
- 4 Open-market sale President, R&D sold 8,100 shares at $23.07 ($186,867)
- 4 Open-market sale President, R&D sold 15,000 shares at $25.00 ($375,000)
- 4 Open-market sale President, R&D sold 8,000 shares at $20.00 ($160,000)
- 4 Open-market sale Chief Administrative Officer sold 452 shares at $21.27 ($9,614)
- 4 Open-market sale Chief Financial Officer sold 734 shares at $21.26 ($15,605)
- 4 Open-market sale President, R&D sold 1,835 shares at $21.27 ($39,030)
- 4 Open-market sale Chief Legal Officer sold 734 shares at $21.27 ($15,612)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award President and CEO acquired 814 shares (grant or award)
- 4 Open-market sale President, R&D sold 8,000 shares at $20.00 ($160,000)
Page 11 of 16 · 320 filings